Bicycle Therapeutics plc

BCYCNASDAQHealthcareBiotechnology

$3.60- (-)1Y −58.38%

As of Oct 15, 2026 close

Market cap: $251.30M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $3.33$9.08
Volume (live): -
Avg. volume (3M): 495.03K

Bicycle Therapeutics plc (BCYC) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Bicycle Therapeutics plc stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy

Based on 6 unique analysts

(7 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$9.25

+156.94% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest BCYC Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Aug 17, 2026	Maxwell Skor	Morgan Stanley	Maintains	Hold	-
Jul 31, 2026	Gregory Renza	Truist	Maintains	Hold	$7.00
Jul 31, 2026	Tara Bancroft	TD Cowen	Maintains	Buy	-
Jul 31, 2026	Jeff Jones	Oppenheimer	Initiates	Buy	$36.00 → $11.00 −25.00 (−69.4%)
Jul 30, 2026	Tara Bancroft	TD Cowen	Maintains	Buy	-
Jul 30, 2026	Ami Fadia	Needham	Maintains	Buy	$15.00 → $14.00 −1.00 (−6.7%)
Jul 30, 2026	Leonid Timashev	RBC Capital	Maintains	Hold	$5.00

Maxwell Skor

Morgan Stanley

HoldMaintains

Aug 17

Gregory Renza

Truist

HoldMaintains

$7.00

Jul 31

Tara Bancroft

TD Cowen

BuyMaintains

Jul 31

Jeff Jones

Oppenheimer

BuyInitiates

$36.00 → $11.00

Jul 31

Tara Bancroft

TD Cowen

BuyMaintains

Jul 30

Ami Fadia

Needham

BuyMaintains

$15.00 → $14.00

Jul 30

Leonid Timashev

RBC Capital

HoldMaintains

$5.00

Jul 30

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Aug 17, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BCYC?

The analyst consensus rating for BCYC is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for BCYC?

The average 12-month price target for BCYC is $9.25, representing an upside of 156.9% from the Oct 15, 2026 close of $3.60.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.